Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures.
about
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta poresImpaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's DiseaseApproaching ryanodine receptor therapeutics from the calcin angle.Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.Ryanodine receptors: physiological function and deregulation in Alzheimer disease.Dantrolene, a treatment for Alzheimer disease?Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.Ionomycin-induced calcium influx induces neurite degeneration in mouse neuroblastoma cells: analysis of a time-lapse live cell imaging system.Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?Emerging pathways driving early synaptic pathology in Alzheimer's disease.Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.Familial Alzheimer's disease-associated presenilin 1 mutants promote γ-secretase cleavage of STIM1 to impair store-operated Ca2+ entry.Intracellular Ca2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer's disease.On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases.Role of presynaptic calcium stores for neural network dysfunction in Alzheimer's disease.Dysregulation of Intracellular Calcium Signaling in Alzheimer's DiseaseA mathematical model for the effects of amyloid beta on intracellular calcium
P2860
Q26738355-E5C86979-D3A2-4850-B2AA-82CE24C23534Q36268875-12726633-1E44-4167-8B63-EE79BA704FE9Q36837539-10E0122C-E181-4BD9-98F4-3B2CD8CF7DA1Q37715875-E5E34B25-55E5-48C4-8979-7C3965C17BC8Q38217975-D39023E0-ED18-43C7-A834-2ABD79E7486CQ38304771-9DAE52CD-2605-4006-BF47-5A5C615F2F9BQ38718079-F87F1457-48EF-424A-97B3-D9517AA1A680Q38749124-59D49B23-4EFB-4A17-A0A4-3A5E654D80E4Q38958106-0EEB4F43-0809-4D54-BC97-9BF226310FDAQ38962140-C6605412-DE8D-44AE-BA80-D7D304E80B52Q40410650-431C1962-F6B7-4990-9FDD-A2105AFEFE74Q42078669-6F5AD127-763F-4B5F-84BC-1A52EC123B5CQ49873932-8EA27EF6-3BA0-47DE-B000-75420C279304Q52721231-34830B53-91B3-4183-87C7-2D79CBF2B7D1Q55561442-AC33D58D-5BA7-443A-9AA8-FB384478F2DFQ57131389-B1C221F6-3170-4BA1-BA3F-062E444B8FA3Q58722978-2E225108-B416-4F07-BCCF-1C4AC8D5A65D
P2860
Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Calcium channelopathies and Al ...... rapeutic success and failures.
@ast
Calcium channelopathies and Al ...... rapeutic success and failures.
@en
Calcium channelopathies and Al ...... rapeutic success and failures.
@nl
type
label
Calcium channelopathies and Al ...... rapeutic success and failures.
@ast
Calcium channelopathies and Al ...... rapeutic success and failures.
@en
Calcium channelopathies and Al ...... rapeutic success and failures.
@nl
prefLabel
Calcium channelopathies and Al ...... rapeutic success and failures.
@ast
Calcium channelopathies and Al ...... rapeutic success and failures.
@en
Calcium channelopathies and Al ...... rapeutic success and failures.
@nl
P1476
Calcium channelopathies and Al ...... rapeutic success and failures.
@en
P2093
Grace E Stutzmann
Shreaya Chakroborty
P356
10.1016/J.EJPHAR.2013.11.012
P407
P577
2013-12-06T00:00:00Z